InvestorsHub Logo
Followers 51
Posts 4564
Boards Moderated 0
Alias Born 12/14/2009

Re: None

Wednesday, 09/11/2019 4:01:11 PM

Wednesday, September 11, 2019 4:01:11 PM

Post# of 690787
If DCVax-L show positive P3 results,the value of the DCVAX platform will be estimated >$10b. Because Merck just shown interest in it and calls it the next step in immunotherapy.
A minimum buyout offer is $8b. $8b/1.2 fully diluted shares = $6,67/share

On the other hand I have seen buyouts happening in the oncology sector for $50b as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News